BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Isakov V, Goncharov A. Breaking barriers in the first-line Helicobacter pylori treatment: Chinese multicenter trial validates vonoprazan-based triple therapy. World J Gastroenterol 2025; 31(40): 112312 [PMID: 41180991 DOI: 10.3748/wjg.v31.i40.112312]
URL: https://www.wjgnet.com/1007-9327/full/v31/i40/112312.htm
Number Citing Articles